5C59.0

ICD-11 MMS 2026-01

Disorders of biogenic amine metabolism

Exclusions from above levels

  • http://id.who.int/icd/entity/1191191920 – Disorders of lipoprotein metabolism or certain specified lipidaemias
  • 3A10.Z – Hereditary haemolytic anaemia due to enzyme deficiency
  • 5A71.01 – Congenital adrenal hyperplasia
Show allHide
  • 5A81.1 – 5-alpha-reductase deficiency
  • LD28.01 – Marfan syndrome
  • LD28.1 – Ehlers-Danlos syndrome
  • LD2A.4 – androgen resistance syndrome
  • 18 – Pregnancy, childbirth or the puerperium
  • http://id.who.int/icd/entity/1004987305 – Transitory endocrine or metabolic disorders specific to fetus or newborn

Child codes

  • 5C59.00 – Disorders of catecholamine synthesis
  • 5C59.01 – Disorders of pterin metabolism
  • 5C59.0Y – Other specified disorders of biogenic amine metabolism
  • 5C59.0Z – Disorders of biogenic amine metabolism, unspecified

Sibling codes

  • 5C59.1 – Disorders of gamma aminobutyric acid metabolism
  • 5C59.2 – Disorders of pyridoxine metabolism
  • 5C59.Y – Other specified inborn errors of neurotransmitter metabolism
  • 5C59.Z – Inborn errors of neurotransmitter metabolism, unspecified

Foundation entity

Disorders of biogenic amine metabolism – http://id.who.int/icd/entity/1540943037

Part of: 5C59: Inborn errors of neurotransmitter metabolism › 05: Endocrine, nutritional or metabolic diseases